Walleye Capital’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-27,318
| Closed | -$151K | – | 1993 |
|
|
2025
Q1 | $151K | Buy |
27,318
+10,639
| +64% | +$58.7K | ﹤0.01% | 1468 |
|
|
2024
Q4 | $95.9K | Sell |
16,679
-27,220
| -62% | -$157K | ﹤0.01% | 1697 |
|
|
2024
Q3 | $455K | Buy |
43,899
+21,550
| +96% | +$223K | ﹤0.01% | 1375 |
|
|
2024
Q2 | $290K | Buy |
+22,349
| New | +$290K | ﹤0.01% | 1706 |
|
|
2024
Q1 | – | Sell |
-46,489
| Closed | -$437K | – | 2724 |
|
|
2023
Q4 | $437K | Sell |
46,489
-72,875
| -61% | -$686K | ﹤0.01% | 1210 |
|
|
2023
Q3 | $1.33M | Buy |
119,364
+92,410
| +343% | +$1.03M | ﹤0.01% | 789 |
|
|
2023
Q2 | $577K | Buy |
+26,954
| New | +$577K | ﹤0.01% | 949 |
|
|
2022
Q2 | – | Sell |
-63,046
| Closed | -$4.49M | – | 2410 |
|
|
2022
Q1 | $4.49M | Buy |
63,046
+33,846
| +116% | +$2.41M | 0.12% | 171 |
|
|
2021
Q4 | $2.18M | Buy |
+29,200
| New | +$2.18M | 0.07% | 302 |
|
|
2020
Q2 | – | Sell |
-5,402
| Closed | -$278K | – | 649 |
|
|
2020
Q1 | $278K | Buy |
+5,402
| New | +$278K | 0.06% | 241 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 787 |
|